Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
4.900
+0.070 (1.45%)
At close: Jan 21, 2025, 4:00 PM
4.888
-0.012 (-0.24%)
After-hours: Jan 21, 2025, 6:57 PM EST
Mainz Biomed Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Mainz Biomed.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Mainz Biomed stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $120 | Strong Buy | Maintains | $200 → $120 | +2,348.98% | Mar 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $360 → $200 | Strong Buy | Maintains | $360 → $200 | +3,981.63% | Nov 20, 2023 |
Financial Forecast
Revenue This Year
1.09M
from 895.48K
Increased by 21.95%
Revenue Next Year
1.43M
from 1.09M
Increased by 30.77%
EPS This Year
-24.07
from -64.76
EPS Next Year
-9.38
from -24.07
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.1M | 1.5M | 9.7M |
| Avg | 1.1M | 1.4M | 9.4M |
| Low | 1.1M | 1.4M | 9.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 25.6% | 34.6% | 576.5% |
| Avg | 21.9% | 30.8% | 557.1% |
| Low | 17.3% | 25.6% | 531.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -24.78 | -9.66 | -0.68 |
| Avg | -24.07 | -9.38 | -0.66 |
| Low | -23.13 | -9.02 | -0.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.